Bausch + Lomb Announces Brett Icahn and Gary Hu Have Been Appointed to its Board of Directors

By Staff
Monday, June 27, 2022 12:21 AM VAUGHAN, Ontario—Bausch + Lomb Corp. (NYSE/TSX: BLCO) announced Friday that it has expanded its board of directors to add two designees to the board from Carl C. Icahn and affiliated entities (Icahn Group).

CooperVision Expands New York Manufacturing and Distribution Facilities in Move to ‘Significantly Increase Capacity’

By Staff
Thursday, June 23, 2022 12:18 AM ROCHESTER, N.Y.—To meet growing demand from eyecare professionals and wearers for its portfolio of contact lenses, CooperVision has begun construction on the expansion and renovation of its manufacturing, packaging and distribution facilities in Scottsville and West Henrietta, N.Y.

Texas Attorney General Secures Deceptive Trade Practices Settlement With Hubble Contacts’ Parent Company

By Staff
Tuesday, June 14, 2022 12:21 AM AUSTIN, Texas—Texas Attorney General Ken Paxton said last week that his office had secured a settlement over deceptive trade practices with the parent company of Hubble Contacts.

CooperVision Names Nancy Keir, OD, as Senior Director of Life Cycle Management

By Staff
Tuesday, June 14, 2022 12:18 AM SAN RAMON, Calif.—CooperVision has appointed Nancy Keir, OD, PhD, FBCLA, FAAO, as senior director, life cycle management.

CooperVision Says New MiSight 1 day Prescriber Data Signals Myopia Control 'Confidence' Among ECPs

By Staff
Friday, June 10, 2022 12:18 AM SAN RAMON, Calif.—CooperVision, a leader in myopia management, has announced new data that the company said demonstrates how certified U.S. eyecare practices have embraced MiSight 1 day contact lenses for myopia control.

In First Report as a New Public Company, Bausch + Lomb Reports Increased Sales and Decline in Net Income for its First Quarter

By Staff
Thursday, June 9, 2022 12:24 AM VAUGHAN, Ontario—Bausch + Lomb Corp. (NYSE/TSX: BLCO), in its first financial report since returning to the ranks of independent public companies in May, reported Wednesday that its sales increased 1 percent (5 percent on an organic basis) to $889 million in its first quarter, which ended March 31. The eyecare company also reported net income of $20 million and adjusted EBITDA of $170 million for the first quarter. In the year-ago quarter B+L reported revenue of $881 million. The company noted that in the current quarter foreign exchange had an unfavorable impact on revenue of $29 million.

CooperVision Acquires EnsEyes to Accelerate Nordic Region Specialty Contact Lens Growth

By Staff
Thursday, June 2, 2022 12:24 AM SAN RAMON, Calif.—CooperVision has acquired EnsEyes, the leading supplier of orthokeratology (ortho-k) and scleral contact lenses in Europe’s Nordic region.

CooperVision Specialty EyeCare Partners Now Partners With 25 Universities to Provide Specialty Contact Lenses

By Staff
Wednesday, June 1, 2022 12:15 AM SAN RAMON, Calif.—CooperVision Specialty EyeCare announced the latest iteration of its “Make a Difference” program, which is now entering its third year.

CooperVision Appoints Alex Wilkes as President, Americas

By Staff
Tuesday, May 24, 2022 12:30 AM SAN RAMON, Calif.—CooperVision, one of the world’s leading manufacturers of contact lenses, has named Alex Wilkes as president, Americas, effective June 14. Wilkes brings more than a decade of experience in the eyecare industry, having most recently served as senior vice president and general manager of Pearle Vision at Luxottica Retail. At CooperVision, Wilkes will be responsible for the executive leadership and driving the growth of the company’s largest region, determining the strategic direction for the U.S., Canada and Latin America, according to Monday’s announcement.

Alcon to Acquire Eysuvis in a Move That Adds to Its Ophthalmic Eye Drop Portfolio

By Staff
Tuesday, May 24, 2022 12:27 AM GENEVA—Alcon (SIX/NYSE: ALC) said on Monday that it has signed an agreement to acquire Eysuvis (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala Pharmaceuticals Inc.

CooperCompanies Releases 2021 Environmental, Social and Governance Highlights Report, Signs on to United Nations Global Compact

By Staff
Thursday, May 19, 2022 12:27 AM SAN RAMON, Calif.—CooperCompanies (NYSE: COO) has announced the publication of its 2021 Environmental, Social and Governance (ESG) Highlights Report, sharing the company’s progress on ESG items most important to its businesses and stakeholders, including employees, shareholders, customers and global communities.

Alcon Celebrates 75th Anniversary and Notes its History of Breakthrough Innovation in Eyecare

By Staff
Tuesday, May 17, 2022 12:24 AM GENEVA—On Monday, Alcon marked the company’s 75th anniversary with its “Brilliant History, Brilliant Future” celebration. On May 16, 1947, Alcon Laboratories Inc. was incorporated and began manufacturing specialty pharmaceutical products in Fort Worth, Texas, the company noted in its announcement.

Kits Reports Slight Sales Decline in First Quarter Total Revenue and Notes Large Growth in Eyeglasses Revenue

By Staff
Friday, May 13, 2022 12:24 AM VANCOUVER, Canada—Kits Eyecare Ltd. (TSX: KITS / OTCQX: KTYCF), a direct-to-consumer glasses manufacturer and digital eyecare provider, reported this week that its revenue in the first quarter dipped roughly 2 percent to $20.1 million.

Final Two Companies Reach a Settlement in Long-Running Contact Lens Price-Fixing Suit

By Staff
Friday, May 13, 2022 12:21 AM JACKSONVILLE, Fla.—Bringing a long-running price-fixing case closer to a conclusion, a federal judge in Florida this week gave preliminary approval to proposals from Alcon Vision LLC and Johnson & Johnson Vision Care that would settle their roles in the matter, according to a May 9 court filing.

Alcon Reports Double-Digit Sales Growth in Vision Care, Surgical in First Quarter

By Staff
Thursday, May 12, 2022 12:24 AM GENEVA—Calling its performance “a strong start to the year,” Alcon (SIX/NYSE:ALC) reported that worldwide sales increased 14 percent on a reported basis to $2.2 billion in its first quarter ended March 31.